Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CellAxia Logo
CellAxia Growth Score
68
CB Rank
124367
Heat Score
73
CellAxia is a biotechnology firm that researches, develops, and markets pharmaceuticals and regenerative medicine products.
Founded
obfuscation
PrivateSeries B Tokyo, Tokyo, Japan11-50 www.cellaxia.co.jp/
Biotechnology
Clinical Trials
Health Care
Wellness
Overview

CellAxia
Total Funding
obfuscation
Growth Score
68
Heat Score
73

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score68
-1 pts
in past quarter
Heat Score 73
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About CellAxia

CB Rank
124367
CellAxia is a biotechnology firm that researches, develops, and markets pharmaceuticals and regenerative medicine products.
Founded
obfuscation
PrivateSeries B Tokyo, Tokyo, Japan11-50 www.cellaxia.co.jp/
Biotechnology
Clinical Trials
Health Care
Wellness

Funding Rounds

Series B
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Celaxia Co., Ltd.
Also Known As セルアクシア
Operating Status Active
Company Type For Profit
Founders  Makoto Seki
About the Company
CellAxia is a biotechnology startup that creates medications for cell treatment. Drug discovery bio-venture aiming at the practical application of advanced research such as cell therapy. It serves clients operating in the healthcare sector.
Phone Number +81 03-3527-2448
Contact Email info@cellaxia.co.jp
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

E-MNC (CA-702)
A cell therapy drug candidate targeting autoimmune diseases, currently in Phase 2 clinical trials for treating Sjögren's syndrome.
Direct Conversion (DC) Project
A research and development project focused on creating regenerative medicine therapies by converting cells directly to desired types for treating rare and intractable diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B
obfuscation
Series B - CellAxia Logo
Series B - CellAxia
6
obfuscation
— Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Fukuoka Financial Group Logo
Fukuoka Financial Group
—
Series B - CellAxia Logo
Series B - CellAxia
—
Fukuoka Financial Group Logo
Fukuoka Financial Group
—
Series B - CellAxia Logo
Series B - CellAxia
—
Fukuoka Financial Group Logo
Fukuoka Financial Group
—
Series B - CellAxia Logo
Series B - CellAxia
—
Fukuoka Financial Group Logo
Fukuoka Financial Group
—
Series B - CellAxia Logo
Series B - CellAxia
—
Fukuoka Financial Group Logo
Fukuoka Financial Group
—
Series B - CellAxia Logo
Series B - CellAxia
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

402

Active Website Tech Count

5CellAxia is actively using 5 technologies for its website, according to BuiltWith. These include Euro, CommonCrawl Top 5m, and  Pound Sterling.

Total IP

4The intellectual property of CellAxia includes 4 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is CellAxia's headquarters? CellAxia is located in Tokyo, Tokyo, Japan.Who invested in CellAxia? CellAxia has 7 investors including Fukuoka Financial Group and  Mitsubishi UFJ Capital.When was the last funding round for CellAxia? CellAxia closed its last funding round on
obfuscation
from a Series B round.Who are CellAxia's competitors? Alternatives and possible competitors to CellAxia may include Takeda, Bristol-Myers Squibb, and  BlueRock Therapeutics.How much funding has CellAxia raised to date? CellAxia has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d46e5f 1)
|